BEZABEH; Binyam

Patent Applications and Registrations

Patent applications and USPTO patent grants for BEZABEH; Binyam.The latest application filed is for "combination therapies using anti-pseudomonas psl and pcrv binding molecules".

Company Profile

2.8.13

BEZABEH; Binyam - Gaithersburg MD
Bezabeh; Binyam - Oakland CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules App 20220177554 - DIGIANDOMENICO; Antonio ; et al.	2022-06-09
Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv Grant 11,203,633 - Digiandomenico , et al. December 21, 2	2021-12-21
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules App 20200317757 - DIGIANDOMENICO; Antonio ; et al.	2020-10-08
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules Grant 10,597,439 - Digiandomenico , et al.	2020-03-24
Bispecific HER2 antibodies Grant 10,160,812 - Li , et al. Dec	2018-12-25
Bispecific Her2 Antibodies App 20170291955 - Li; John ; et al.	2017-10-12
Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses Thereof App 20170218067 - Landes; Gregory M. ; et al.	2017-08-03
Multi-specific Anti-pseudomonas Psl And Pcrv Binding Molecules And Uses Thereof App 20170183397 - DIGIANDOMENICO; Antonio ; et al.	2017-06-29
Multispecific And Multivalent Binding Proteins And Uses Thereof App 20170114151 - Dimasi; Nazzareno ; et al.	2017-04-27
Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof Grant 9,580,503 - Landes , et al. February 28, 2	2017-02-28
Multispecific and multivalent binding proteins and uses thereof Grant 9,580,509 - Dimasi , et al. February 28, 2	2017-02-28
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules App 20150284450 - Digiandomenico; Antonio ; et al.	2015-10-08
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules App 20150023966 - Digiandomenico; Antonio ; et al.	2015-01-22
Multispecific And Multivalent Binding Proteins And Uses Thereof App 20140302038 - Dimasi; Nazzareno ; et al.	2014-10-09
Antibodies Against T Cell Immunoglobulin Domain And Mucin Domain 1 (tim-1) Antigen And Uses Thereof App 20120251555 - Landes; Gregory M. ; et al.	2012-10-04
Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof Grant 8,067,544 - Landes , et al. November 29, 2	2011-11-29
Antibodies directed to PDGFD and uses thereof App 20060293506 - Corvalan; Jose R.F. ; et al.	2006-12-28
Antibodies directed to PDGFD and uses thereof Grant 7,135,174 - Corvalan , et al. November 14, 2	2006-11-14
Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof App 20050084449 - Landes, Gregory M. ; et al.	2005-04-21
Antibodies directed to PDGFD and uses thereof App 20030157109 - Corvalan, Jose R. F. ; et al.	2003-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.